Register entry · No. 05375156
VERONA PHARMA LIMITED
Checks
1 warning 12 clear · 1 can't tell yet
-
Warning
Insolvency
1 insolvency filing, latest 30 Jun 2026: Solvency Statement dated 29/06/26
Filing history · See it
The other 13 checks
-
Can't tell
Last filed accounts
No figures held. They come from accounts filed online since January 2016 (older years still loading).
Filed accounts · See it · What this means -
Clear
Company status
Active.
Companies House register -
Clear
Strike-off notices
No strike-off notice in the last three years.
Filing history (The Gazette notices) · See it -
Clear
Accounts on time
Next due 31 Dec 2026.
Companies House register -
Clear
Confirmation statement on time
Next due 10 Mar 2027.
Companies House register -
Clear
Disqualified directors
None of the 3 current officers checked are disqualified.
Companies House disqualified directors register · See it -
Clear
Directors
3 current directors; 1 left in the last 12 months.
Officers on the register · See it -
Clear
Owners
1 owner on file.
People with significant control · See it -
Clear
Charges
None outstanding (13 paid off).
Companies House register -
Clear
Trading history
Incorporated 24 Feb 2005 (21 years ago).
Companies House register -
Clear
Name changes
Never renamed.
Names over time -
Clear
Year-end changes
Not changed in three years.
Filing history (form AA01) · See it -
Clear
Office moves
Moved 1 time in two years.
Filing history (form AD01) · See it
From the public register, filing history, officers, owners and filed accounts, as of 18 Nov 2026. Not a credit score or advice: open the filings before relying on them. JSON
-
Registered office
Change the address120 MOORGATE, LONDON, UNITED KINGDOM, EC2M 6UR
As filed with Companies House. -
Nature of business
- 72110 Research and experimental development on biotechnology
-
Accounts
- Next due
- 31 Dec 2026
- Last made up to
- 31 Dec 2024
- Type
- GROUP
-
Confirmation statement
- Next due
- 10 Mar 2027
- Last made up to
- 24 Feb 2026
-
Charges
- Outstanding
- 0
- All time
- 13
-
Names
- VERONA PHARMA LIMITED current
Figures
No figures held yet. They come from accounts filed online since January 2016; years before 2025 are still loading, newest first.
Public contracts
No contracts found on Find a Tender under this company number.
Matching is by Companies House number only, so contracts filed without the number are not shown.
Contains public sector information licensed under the Open Government Licence v3.0. Source: Find a Tender award notices. JSON
Tenders this company could bid for
7 open
-
Nuclear Decommissioning Authority
University Interactions - NDA Research Portfolio - Single Supplier Framework
-
British Council
-
Agriculture and Horticulture Development Board
-
The Department for Science, Innovation & Technology (DSIT)
-
Intellectual Property Office
Matched on the company's registered business type and the tender's procurement codes. It is a starting point: check each tender's requirements before bidding.
Kestrel, our sister site, explains UK public tenders in plain English and helps you apply. Find tenders for your firm
People
Officers All 33, with past →
| Name | Role | Appointed | Resigned | Born | Nationality · lives in |
|---|---|---|---|---|---|
| Benjamin Paul Lucas Company Director | Director | 7 Oct 2025 | — | November 1974 | British · United Kingdom |
| Martin Ian Rogers | Director | 17 Feb 2026 | — | June 1968 | British · United Kingdom |
| Peter James O'Shaughnessy | Director | 3 Jul 2026 | — | June 1970 | British · United Kingdom |
Owners and controllers All 2, with past →
| Name | Control | Notified | Ceased | Born | Nationality · lives in |
|---|---|---|---|---|---|
| Merck & Co., Inc company · 7954610000 · United States Minor Outlying Islands | Ownership of shares 75 to 100 percent; Voting rights 75 to 100 percent; Right to appoint and remove directors | 7 Oct 2025 | — | — |
From the public register. We show month and year of birth only, and no addresses. Privacy and your data
Ask about this company
Questions
Is VERONA PHARMA LIMITED still trading?
The register shows VERONA PHARMA LIMITED as active.
What does VERONA PHARMA LIMITED do?
It files the industry code 72110 (Research and experimental development on biotechnology).
When was VERONA PHARMA LIMITED set up?
It was incorporated on 24 February 2005.
When are VERONA PHARMA LIMITED's accounts due?
Next accounts are due by 31 December 2026. The last accounts were made up to 31 December 2024.
When is VERONA PHARMA LIMITED's next confirmation statement due?
By 10 March 2027.
Who runs VERONA PHARMA LIMITED?
VERONA PHARMA LIMITED has 3 current directors. They're listed under People on this page.
Similar companies
Same industry code (72110), active, set up around the same time. More in this industry →
- 05661401 UOB TRAINING LIMITED Active 72110 · Research and experimental development on biotechnology
- 05659765 BROADMIND SCIENCE LIMITED Active 72110 · Research And Experimental Development On Biotechnology
- 05660603 J R BIOMEDICAL LIMITED Active 72110 · Research and experimental development on biotechnology
- 05643835 ANH CONSULTANCY LIMITED Active 72110 · Research and experimental development on biotechnology
- 05606880 IHG PHARMACO LIMITED Active 72110 · Research and experimental development on biotechnology
The file
3 of 3 free downloads left today · Last 5 years' accounts as one zip (1 credit a PDF)
| Date | Form | Description | Pages | Document |
|---|---|---|---|---|
| 22 Jul 2026 | TM01 | Director left: Ebru Can Temucin | 1 | PDF ↓ |
| 22 Jul 2026 | AP01 | Director appointed: Peter James O'shaughnessy | 2 | PDF ↓ |
| 7 Jul 2026 | SH02 | Capital alter shares consolidation, 29 Jun 2026 | 4 | PDF ↓ |
| 7 Jul 2026 | RESOLUTIONS | Resolutions | 2 | PDF ↓ |
| 30 Jun 2026 | SH19 | Capital statement capital company with date currency figure, 30 Jun 2026 | 3 | PDF ↓ |
| 30 Jun 2026 | SH20 | Statement by Directors | 1 | PDF ↓ |
| 30 Jun 2026 | CAP-SS | Solvency Statement dated 29/06/26 | 2 | PDF ↓ |
| 30 Jun 2026 | RESOLUTIONS | Resolutions | 5 | PDF ↓ |
| 29 May 2026 | TM02 | Secretary left: Ben Harber | 1 | PDF ↓ |
| 27 May 2026 | RESOLUTIONS | Resolutions | 2 | PDF ↓ |
| 27 May 2026 | MA | Memorandum articles | 27 | PDF ↓ |
| 24 May 2026 | SH08 | Capital name of class of shares | 2 | PDF ↓ |
| 22 May 2026 | SH10 | Capital variation of rights attached to shares | 2 | PDF ↓ |
| 15 May 2026 | CS01 | Confirmation statement, with changes, made up to 24 Feb 2026 | 7 | PDF ↓ |
| 22 Apr 2026 | RP01AP01 | Replacement filing of director appointment with name: Ebru Can Temucin | 3 | PDF ↓ |
| 22 Apr 2026 | RP01AP01 | Replacement filing of director appointment with name: Mr Benjamin Lucas | 3 | PDF ↓ |
| 25 Feb 2026 | AP01 | Director appointed: Mr Martin Ian Rogers | 2 | PDF ↓ |
| 9 Jan 2026 | AD01 | Registered office changed | 1 | PDF ↓ |
| 22 Oct 2025 | MAR | Re registration memorandum articles | 27 | PDF ↓ |
| 22 Oct 2025 | CERT10 | Certificate re registration public limited company to private | 1 | PDF ↓ |
| 22 Oct 2025 | RR02 | Reregistration public to private company | 2 | PDF ↓ |
| 22 Oct 2025 | RESOLUTIONS | Resolutions | 1 | PDF ↓ |
| 16 Oct 2025 | PSC02 | Person with significant control added | 2 | PDF ↓ |
| 16 Oct 2025 | PSC09 | Withdrawal of a person with significant control statement | 2 | PDF ↓ |
| 10 Oct 2025 | MA | Memorandum articles | 27 | PDF ↓ |
| 9 Oct 2025 | OC | Scheme of arrangement | 11 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Kenneth Thomas Cunningham | 1 | PDF ↓ |
| 8 Oct 2025 | AD02 | Change sail address company with old address new address | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Martin William Edwards | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Lisa Deschamps | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: David Raymond Ebsworth | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: James Aloysius Brady | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Mahendra Shah | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Sven Anders Ullman | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Vikas Sinha | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: David Scott Zaccardelli | 1 | PDF ↓ |
| 8 Oct 2025 | AP01 | Director appointed: Mr Ebru Can Temucin | 3 | PDF ↓ |
| 8 Oct 2025 | AP01 | Director appointed: Mr Benjamin Lucas | 3 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Christina Ackermann | 1 | PDF ↓ |
| 8 Oct 2025 | TM01 | Director left: Michael Austwick | 1 | PDF ↓ |
| 8 Oct 2025 | MA | Memorandum articles | 59 | PDF ↓ |
| 8 Oct 2025 | MA | Memorandum articles | 59 | PDF ↓ |
| 7 Oct 2025 | MR04 | Charge satisfied | 1 | PDF ↓ |
| 7 Oct 2025 | MR04 | Charge satisfied | 1 | PDF ↓ |
| 7 Oct 2025 | MR04 | Charge satisfied | 1 | PDF ↓ |
| 7 Oct 2025 | MR04 | Charge satisfied | 1 | PDF ↓ |
| 2 Oct 2025 | RESOLUTIONS | Resolutions | 3 | PDF ↓ |
| 20 May 2025 | SH08 | Capital name of class of shares | 2 | PDF ↓ |
| 20 May 2025 | SH10 | Capital variation of rights attached to shares | 2 | PDF ↓ |
| 1 May 2025 | RESOLUTIONS | Resolutions | 2 | PDF ↓ |
Source: Companies House, data file of 2026-11-01 and its live updates. View on Companies House